Studies of the Etiology of Rheumatoid Arthritis (SERA) is funded by a National Institutes of Health grant and includes four networks including the University of Colorado Medical Center and the University of Nebraska Medical Center. The principal investigator for SERA is Mike Holers, M.D., of the University of Colorado.
The purpose of the study is to identify established and new blood and genetic markers, look for the presence of various antibodies in the blood of healthy people, (these antibodies may be present before physical symptoms of the disease are evident.), and identify possible environmental factors that could contribute to RA. The overall goal of the research is to find mechanisms for earlier diagnosis and possible prevention of RA in the future.
Candidates for this study are close family members (mothers, fathers, brothers, sisters or children) of patients with rheumatoid arthritis. They must be at least 18 years old and they must not already have RA.
For more information about the SERA study at the University of Nebraska Medical Center, call 402-559-4873. To participate in the Denver area call 1 (800) 363-5819 toll free.
To locate other clinical trials around the country, see my June 12th blog titled, “Clinical Trials for Patients With Rheumatoid Arthritis.” It contains links to lists of clinical trials around the country and contact information.
Published On: October 13, 2006